-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Issuer symbol
-
EFX
-
Transactions as of
-
11 Feb 2025
-
Transactions value $
-
$-2,376,073
-
Form type
-
4
-
Filing time
-
13 Feb 2025, 16:13:54 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EFX |
Common Stock |
Award |
$0 |
+2,373 |
+6.14% |
$0.000000 |
41,027 |
11 Feb 2025 |
Direct |
F1 |
| transaction |
EFX |
Common Stock |
Tax liability |
$-449,075 |
-1,775 |
-4.33% |
$253.00 |
39,252 |
11 Feb 2025 |
Direct |
F1 |
| transaction |
EFX |
Common Stock |
Options Exercise |
$1,998,768 |
+13,367 |
+34.1% |
$149.53 |
52,619 |
12 Feb 2025 |
Direct |
F1, F2 |
| transaction |
EFX |
Common Stock |
Options Exercise |
$767,567 |
+5,544 |
+10.5% |
$138.45 |
58,163 |
12 Feb 2025 |
Direct |
F1, F2 |
| transaction |
EFX |
Common Stock |
Sale |
$-4,693,332 |
-18,911 |
-32.5% |
$248.18 |
39,252 |
12 Feb 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-5,544 |
-100% |
$0.000000 |
0 |
12 Feb 2025 |
Common Stock |
5,544 |
$138.45 |
Direct |
|
| transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-13,367 |
-100% |
$0.000000 |
0 |
12 Feb 2025 |
Common Stock |
13,367 |
$149.53 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: